{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:09:39Z","timestamp":1787670579280,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1038\/bjc.2017.229","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T18:45:36Z","timestamp":1500576336000},"page":"835-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Active multiple myeloma suppresses and typically eliminates coexisting MGUS"],"prefix":"10.1038","volume":"117","author":[{"given":"John P","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L J","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankalp","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaheer","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Anthony","family":"Child","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham H","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M","family":"Bunce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T","family":"Drayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"issue":"1","key":"BFbjc2017229_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/leu.2012.159","volume":"27","author":"A Bradwell","year":"2013","unstructured":"Bradwell A, Harding S, Fourrier N, Mathiot C, Attal M, Moreau P, Harousseau JL, Avet-Loiseau H (2013) Prognostic utility of intact immunoglobulin Ig'kappa\/Ig'lambda ratios in multiple myeloma patients. Leukemia 27 (1): 202\u2013207.","journal-title":"Leukemia"},{"issue":"9727","key":"BFbjc2017229_CR2","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","volume":"375","author":"A Dispenzieri","year":"2010","unstructured":"Dispenzieri A, Katzmann JA, Kyle RA, Larson DR, Melton LJ 3rd, Colby CL, Therneau TM, Clark R, Kumar SK, Bradwell A, Fonseca R, Jelinek DF, Rajkumar SV (2010) Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. Lancet 375 (9727): 1721\u20131728.","journal-title":"Lancet"},{"issue":"1","key":"BFbjc2017229_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.rce.2014.07.003","volume":"215","author":"P Garcia-Garcia","year":"2015","unstructured":"Garcia-Garcia P, Enciso-Alvarez K, Diaz-Espada F, Vargas-Nunez JA, Moraru M, Yebra-Bango M (2015) Biclonal gammopathies: Retrospective study of 47 patients. Rev Clin Esp 215 (1): 18\u201324.","journal-title":"Rev Clin Esp"},{"issue":"10","key":"BFbjc2017229_CR4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.leukres.2012.05.008","volume":"36","author":"S Guastafierro","year":"2012","unstructured":"Guastafierro S, Ferrara MG, Sica A, Parascandola RR, Santangelo S, Falcone U (2012) Serum double monoclonal components and hematological malignancies: only a casual association? Review of 34 cases. Leuk Res 36 (10): 1274\u20131277.","journal-title":"Leuk Res"},{"issue":"10","key":"BFbjc2017229_CR5","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/leu.2014.110","volume":"28","author":"E Kastritis","year":"2014","unstructured":"Kastritis E, Zagouri F, Symeonidis A, Roussou M, Sioni A, Pouli A, Delimpasi S, Katodritou E, Michalis E, Michael M, Hatzimichael E, Vassou A, Repousis P, Christophoridou A, Kartasis Z, Stefanoudaki E, Megalakaki C, Giannouli S, Kyrtsonis MC, Konstantopoulos K, Spyroupoulou-Vlachou M, Terpos E, Dimopoulos MA Greek Myeloma Study G (2014) Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma. Leukemia 28 (10): 2075\u20132079.","journal-title":"Leukemia"},{"issue":"1","key":"BFbjc2017229_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/leu.2012.189","volume":"27","author":"JA Katzmann","year":"2013","unstructured":"Katzmann JA, Clark R, Kyle RA, Larson DR, Therneau TM, Melton LJ 3rd, Benson JT, Colby CL, Dispenzieri A, Landgren O, Kumar S, Bradwell AR, Cerhan JR, Rajkumar SV (2013) Suppression of uninvolved immunoglobulins defined by heavy\/light chain pair suppression is a risk factor for progression of MGUS. Leukemia 27 (1): 208\u2013212.","journal-title":"Leukemia"},{"issue":"1","key":"BFbjc2017229_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78 (1): 21\u201333.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"BFbjc2017229_CR8","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0002-9343(81)90326-0","volume":"71","author":"RA Kyle","year":"1981","unstructured":"Kyle RA, Robinson RA, Katzmann JA (1981) The clinical aspects of biclonal gammopathies. Review of 57 cases. Am J Med 71 (6): 999\u20131008.","journal-title":"Am J Med"},{"issue":"13","key":"BFbjc2017229_CR9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMoa054494","volume":"354","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, Dispenzieri A, Katzmann JA, Melton LJ 3rd (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354 (13): 1362\u20131369.","journal-title":"N Engl J Med"},{"issue":"7","key":"BFbjc2017229_CR10","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/leu.2014.34","volume":"28","author":"O Landgren","year":"2014","unstructured":"Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R, Kumar SK, Dispenzieri A, Greenberg AJ, Therneau TM, Melton LJ 3rd, Caporaso N, Korde N, Roschewski M, Costello R, McQuillan GM, Rajkumar SV (2014) Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia 28 (7): 1537\u20131542.","journal-title":"Leukemia"},{"issue":"22","key":"BFbjc2017229_CR11","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, Dispenzieri A, Kumar S, Clark RJ, Baris D, Hoover R, Rajkumar SV (2009) Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113 (22): 5412\u20135417.","journal-title":"Blood"},{"issue":"3","key":"BFbjc2017229_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ajh.24268","volume":"91","author":"H Ludwig","year":"2016","unstructured":"Ludwig H, Milosavljevic D, Berlanga O, Zojer N, Hubl W, Fritz V, Harding S (2016) Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed\/refractory patients with myeloma. Am J Hematol 91 (3): 295\u2013301.","journal-title":"Am J Hematol"},{"issue":"5","key":"BFbjc2017229_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ajh.24319","volume":"91","author":"TC Mullikin","year":"2016","unstructured":"Mullikin TC, Rajkumar SV, Dispenzieri A, Buadi FK, Lacy MQ, Lin Y, Dingli D, Go RS, Hayman SR, Zeldenrust SR, Russell SJ, Lust JA, Leung N, Kapoor P, Kyle RA, Gertz MA, Kumar SK (2016) Clinical characteristics and outcomes in biclonal gammopathies. Am J Hematol 91 (5): 473\u2013475.","journal-title":"Am J Hematol"},{"issue":"1","key":"BFbjc2017229_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0609.1986.tb02658.x","volume":"36","author":"T Nilsson","year":"1986","unstructured":"Nilsson T, Norberg B, Rudolphi O, Jacobsson L (1986) Double gammopathies: incidence and clinical course of 20 patients. Scand J Haematol 36 (1): 103\u2013106.","journal-title":"Scand J Haematol"},{"issue":"2","key":"BFbjc2017229_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/0090-1229(80)90097-5","volume":"17","author":"W Pruzanski","year":"1980","unstructured":"Pruzanski W, Gidon MS, Roy A (1980) Suppression of polyclonal immunoglobulins in multiple myeloma: relationship to the staging and other manifestations at diagnosis. Clin Immunol Immunopathol 17 (2): 280\u2013286.","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"BFbjc2017229_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00005792-198605000-00001","volume":"65","author":"S Riddell","year":"1986","unstructured":"Riddell S, Traczyk Z, Paraskevas F, Israels LG (1986) The double gammopathies. Clinical and immunological studies. Medicine (Baltimore) 65 (3): 135\u2013142.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"BFbjc2017229_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood-2013-05-505487","volume":"123","author":"I Turesson","year":"2014","unstructured":"Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, Landgren O (2014) Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood 123 (3): 338\u2013345.","journal-title":"Blood"},{"issue":"10","key":"BFbjc2017229_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","volume":"85","author":"RK Wadhera","year":"2010","unstructured":"Wadhera RK, Rajkumar SV (2010) Prevalence of monoclonal gammopathy of undetermined significance: a systematic review. Mayo Clin Proc 85 (10): 933\u2013942.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"BFbjc2017229_CR19","first-page":"274","volume":"31","author":"L Wang","year":"2001","unstructured":"Wang L, Young DC (2001) Suppression of polyclonal immunoglobulin production by M-proteins shows isotype specificity. Ann Clin Lab Sci 31 (3): 274\u2013278.","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"BFbjc2017229_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.0954-6820.1987.tb01275.x","volume":"221","author":"A Wangel","year":"1987","unstructured":"Wangel A (1987) Multiple myeloma and polyclonal hypogammaglobulinaemia. Acta Med Scand 221 (5): 421\u2013425.","journal-title":"Acta Med Scand"},{"issue":"22","key":"BFbjc2017229_CR21","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM (2009) A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 113 (22): 5418\u20135422.","journal-title":"Blood"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2017229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017229","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bjc.2017.229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2017229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T09:38:39Z","timestamp":1684402719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2017229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["BFbjc2017229"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.229","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]},"assertion":[{"value":"1 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}